Moreover, the function of GTSE1 was further validated in vivo, where knockdown of GTSE1 reduced the volume and weight of xenograft tumors following CDDP treatment, whereas overexpression of GTSE1 blocked the tumor-eliminating role of CDDP. The gene discussed is GTSE1; the disease is neoplasm.